questionText: To ask the Secretary of State for Health and Social Care, what estimate he has made of the potential impact of the introduction of the respiratory syncytial virus vaccine for people aged between 75 and 79 on the number (a) deaths, (b) hospital admissions 
answerText: The UK Health Security Agency’s (UKHSA) analysis in the Lancet journal in April indicated 30% fewer respiratory syncytial virus hospital admissions in 75- to 79-year-olds than would have occurred without vaccination. This was seen after around 40% of elig...
heading: Respiratory Syncytial Virus: Vaccination